Reported Standalone quarterly numbers for Orchid Pharma are:Net Sales at Rs 148.45 crore in December 2018 up 2.92% from Rs. 144.24 crore in December 2017.
Quarterly Net Loss at Rs. 18.47 crore in December 2018 up 76.08% from Rs. 77.23 crore in December 2017.
EBITDA stands at Rs. 14.40 crore in December 2018 down 34.4% from Rs. 21.95 crore in December 2017.
Orchid Pharma shares closed at 3.30 on February 12, 2019 (NSE) and has given -58.75% returns over the last 6 months and -81.09% over the last 12 months.
| Orchid Pharma |
| Standalone Quarterly Results |
in Rs. Cr. |
|
|
Dec'18 |
Sep'18 |
Dec'17 |
| Net Sales/Income from operations |
148.45 |
142.48 |
144.24 |
| Other Operating Income |
-- |
-- |
-- |
| Total Income From Operations |
148.45 |
142.48 |
144.24 |
| EXPENDITURE |
| Consumption of Raw Materials |
70.63 |
70.45 |
63.29 |
| Purchase of Traded Goods |
0.08 |
0.10 |
0.34 |
| Increase/Decrease in Stocks |
0.00 |
-10.86 |
-0.23 |
| Power & Fuel |
-- |
-- |
-- |
| Employees Cost |
18.79 |
19.49 |
19.54 |
| Depreciation |
32.84 |
32.96 |
33.48 |
| Excise Duty |
-- |
-- |
-- |
| Admin. And Selling Expenses |
-- |
-- |
-- |
| R & D Expenses |
-- |
-- |
-- |
| Provisions And Contingencies |
-- |
-- |
-- |
| Exp. Capitalised |
-- |
-- |
-- |
| Other Expenses |
46.45 |
66.54 |
47.71 |
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
-20.33 |
-36.19 |
-19.89 |
| Other Income |
1.90 |
6.28 |
8.36 |
| P/L Before Int., Excpt. Items & Tax |
-18.44 |
-29.91 |
-11.53 |
| Interest |
0.03 |
-- |
76.18 |
| P/L Before Exceptional Items & Tax |
-18.47 |
-29.91 |
-87.70 |
| Exceptional Items |
-- |
6.78 |
-- |
| P/L Before Tax |
-18.47 |
-23.13 |
-87.70 |
| Tax |
-- |
-0.01 |
-10.47 |
| P/L After Tax from Ordinary Activities |
-18.47 |
-23.13 |
-77.23 |
| Prior Year Adjustments |
-- |
-- |
-- |
| Extra Ordinary Items |
-- |
-- |
-- |
| Net Profit/(Loss) For the Period |
-18.47 |
-23.13 |
-77.23 |
| Equity Share Capital |
88.96 |
88.96 |
88.96 |
| Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
| Equity Dividend Rate (%) |
-- |
-- |
-- |
| EPS Before Extra Ordinary |
| Basic EPS |
-2.08 |
-2.60 |
-8.68 |
| Diluted EPS |
-2.08 |
-2.60 |
-8.68 |
| EPS After Extra Ordinary |
| Basic EPS |
-2.08 |
-2.60 |
-8.68 |
| Diluted EPS |
-2.08 |
-2.60 |
-8.68 |
| Public Share Holding |
| No Of Shares (Crores) |
-- |
-- |
-- |
| Share Holding (%) |
-- |
-- |
-- |
| Promoters and Promoter Group Shareholding |
| a) Pledged/Encumbered |
| - Number of shares (Crores) |
-- |
-- |
-- |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
| b) Non-encumbered |
| - Number of shares (Crores) |
-- |
-- |
-- |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
| Source : Dion Global Solutions Limited |
|
